Alipogene Tiparvovec is a gene therapy drug used to treat lipoprotein lipase deficiency (LPLD). It is a one-time injection that is designed to replace the defective gene responsible for the condition. It is the first gene therapy approved by the US Food and Drug Administration (FDA) for the treatment of a genetic disorder.